Monroe Capital (MRCC) Q3 2024 earnings summary
Event summary combining transcript, slides, and related documents.
Q3 2024 earnings summary
14 Jan, 2026Executive summary
Adjusted net investment income covered the $0.25 per share dividend for the 18th consecutive quarter, with a total annualized dividend yield over 12% based on the November 11th, 2024, closing price.
Net investment income for Q3 2024 was $6.6 million ($0.31 per share), with a net increase in net assets from operations of $5.0 million ($0.23 per share).
Net asset value (NAV) was $198.9 million ($9.18 per share) as of September 30, 2024, down from $199.3 million ($9.20 per share) at June 30, 2024, and $9.40 at year-end 2023.
Portfolio composition remained stable, with 79.2%–80% in senior secured/first lien loans and 13.6% in equity securities at quarter-end.
A strategic partnership was announced with the Wendel Group, which will acquire a majority stake in Monroe and commit $1 billion in new seed capital; the transaction is expected to close in Q1 2025.
Financial highlights
Total investment income for Q3 2024 was $15.7 million, up $0.1 million sequentially and flat year-over-year, mainly due to higher fee income.
Net realized gains for the nine months were $1.1 million, compared to a $39.1 million loss in the prior year period.
Net loss for the quarter was $1.5 million, improved from a $3.3 million net loss in the prior quarter, primarily due to unrealized mark-to-market losses.
Operating expenses decreased to $9.1 million in Q3 2024 from $10.1 million in Q3 2023, mainly due to lower incentive fees.
Distributions to stockholders totaled $0.75 per share for the nine months, consistent with the prior year.
Outlook and guidance
Management expects a more active middle market deal environment through the rest of 2024 and into 2025, driven by increased private equity activity and lower interest rates.
Focus remains on redeploying capital into accretive opportunities and maintaining stable dividends.
The Wendel partnership is expected to provide additional capital, scale, and strategic benefits.
Elevated interest rates and a softening macroeconomic environment could increase default rates, but scale and diversification are expected to help navigate risks.
Latest events from Monroe Capital
- Both asset sale and merger proposals were approved by a majority of outstanding shares.MRCC
EGM 202613 Mar 2026 - Supplemental distributions and enhanced merger terms were approved to address shareholder concerns.MRCC
Proxy Filing11 Mar 2026 - Supplement updates proxy materials for a proposed transaction, referencing recent filings.MRCC
Proxy Filing6 Mar 2026 - Net investment income and NAV declined year-over-year, with merger expected to unlock value.MRCC
Q4 20255 Mar 2026 - Director election and share sale authorization approved; no shareholder questions raised.MRCC
AGM 20243 Feb 2026 - Adjusted NII rose to $0.31/share, covering the dividend as NAV and leverage declined.MRCC
Q2 20242 Feb 2026 - Shareholders to vote on merger and asset sale, with NAV-based share exchange and fee waiver.MRCC
Proxy Filing20 Jan 2026 - Q4 income covered dividends; NAV dipped, but 2025 outlook targets growth and risk discipline.MRCC
Q4 202416 Dec 2025 - Shareholders to vote on unchanged advisory agreement after Wendel acquires 75% of Monroe.MRCC
Proxy Filing2 Dec 2025